Study Information

This study is investigating a biosimilar treatment for rheumatoid arthritis, an autoimmune condition that affects the joints.  A biosimilar drug is designed to look similar and behave the same as a currently approved medication. Often these studies arise when the patent of the existing drug comes to an end.

This study is seeking health volunteers for the purpose of collecting pharmacokinetic and pharmacodynamic data, to compare the study drug with the existing medication.

This study has a group starting every week! Call 1800 243 733 to organise a screening appointment.

  • 2
    Nights Inpatient Stay
  • 11
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy Male and Females aged 18-55yrs
  • Body Mass Index (BMI) between 18-30kg/m²
  • No significant medical conditions or medical history
  • Not currently taking prescription medications